Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis

被引:32
作者
Ikezawa, I [1 ]
Tai, H [1 ]
Shimada, Y [1 ]
Komatsu, Y [1 ]
Galicia, JC [1 ]
Yoshie, H [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Niigata 9518514, Japan
关键词
chronic periodontitis; gingival crevicular fluid; serum; soluble tumour necrosis factor receptor; tumour necrosis factor-alpha;
D O I
10.1111/j.1600-051X.2005.00832.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Soluble types of tumour necrosis factor (TNF) receptors type I and 2 modulate the TNF-alpha-mediated inflammatory responses in chronic periodontitis (CP). Objectives: This study investigated the levels of TNF-alpha, soluble TNF receptor type 1 and 2 in gingival crevicular fluid (GCF) and serum of healthy subjects and CP patients. Materials and Methods: Thirty-eight sera and 73 GCF samples were collected from 16 healthy subjects and 22 CP patients. GCF was collected from probing pocket depth (PPD) <= 3 rum sites of healthy subjects, PPD <= 3, 4-6 and >= 7 mm sites of CP patients. The levels of TNF-a, soluble TNF receptor type 1 and 2 in the serum and GCF were quantified by enzyme-linked immunosorbant assay. Results: The total amounts of TNF-alpha, soluble TNF receptor type I and 2 in GCF significantly elevated with increasing PPD in both site-based (p < 0.05) and subject-based (p < 0.05) analyses. However, their levels progressively diverged as the pocket depths increased, with the soluble TNF receptor type 2 level being comparatively lower than type 1. On the other hand, soluble TNF receptor type 2/type 1 ratios in GCF decreased as the severity of periodontitis increased (p < 0.0001). Conclusion: The imbalance between soluble TNF receptor type I and 2 levels in GCF could be related to CP severity.
引用
收藏
页码:1047 / 1054
页数:8
相关论文
共 25 条
[1]  
Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3
[2]  
Arno A, 1959, J PERIODONTOL, V30, P7, DOI [10.1902/jop.1959.30.1.7, DOI 10.1902/JOP.1959.30.1.7]
[3]  
Assuma R, 1998, J IMMUNOL, V160, P403
[4]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169
[5]   Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis [J].
Delima, AJ ;
Oates, T ;
Assuma, R ;
Schwartz, Z ;
Cochran, D ;
Amar, S ;
Graves, DT .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2001, 28 (03) :233-240
[6]   The influence of interleukin gene polymorphism on expression of interleukin-1β and tumor necrosis factor-α in periodontal tissue and gingival crevicular fluid [J].
Engebretson, SP ;
Lamster, IB ;
Herrera-Abreu, M ;
Celenti, RS ;
Timms, JM ;
Chaudhary, AGA ;
di Giovine, FS ;
Kornman, KS .
JOURNAL OF PERIODONTOLOGY, 1999, 70 (06) :567-573
[7]   Delayed neutrophil apoptosis in chronic periodontitis patients [J].
Gamonal, J ;
Sanz, M ;
O'Connor, A ;
Acevedo, A ;
Suarez, I ;
Sanz, A ;
Martínez, B ;
Silva, A .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2003, 30 (07) :616-623
[8]   Etanercept: therapeutic use in patients with rheumatoid arthritis [J].
Garrison, L ;
McDonnell, ND .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 :65-69
[9]   Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis [J].
Graves, DT ;
Delima, AJ ;
Assuma, R ;
Amar, S ;
Oates, T ;
Cochran, D .
JOURNAL OF PERIODONTOLOGY, 1998, 69 (12) :1419-1425
[10]  
HAYASHI H, 2003, J TOKYO MED U, V61, P248